Date | Time | Source | Headline | Symbol | Company |
07/19/2010 | 6:50AM | GlobeNewswire Inc. | AVI BioPharma Inc. is Today's Focus Stock on MicroStockProfit.com | NASDAQ:AVII | Sarepta Therapeutics, Inc. (MM) |
07/16/2010 | 1:00PM | Marketwired | AVI BioPharma Announces Presentations on Exon Skipping Drug AVI-4658 for Treatment of Duchenne Muscular Dystrophy at Internation | NASDAQ:AVII | Sarepta Therapeutics, Inc. (MM) |
07/16/2010 | 7:45AM | Marketwired | AVI BioPharma Discloses New Contract With U.S. Government for Potential Funding of up to $291 Million to Advance Development of | NASDAQ:AVII | Sarepta Therapeutics, Inc. (MM) |
07/15/2010 | 5:16PM | Edgar (US Regulatory) | Current report filing (8-K) | NASDAQ:AVII | Sarepta Therapeutics, Inc. (MM) |
07/12/2010 | 2:18PM | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:AVII | Sarepta Therapeutics, Inc. (MM) |
07/08/2010 | 1:47PM | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:AVII | Sarepta Therapeutics, Inc. (MM) |
07/07/2010 | 3:16PM | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:AVII | Sarepta Therapeutics, Inc. (MM) |
07/07/2010 | 1:05PM | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:AVII | Sarepta Therapeutics, Inc. (MM) |
07/07/2010 | 8:00AM | Marketwired | AVI BioPharma Opens Investigational New Drug (IND) Application for AVI-4658 in Duchenne Muscular Dystrophy | NASDAQ:AVII | Sarepta Therapeutics, Inc. (MM) |
06/11/2010 | 4:59PM | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:AVII | Sarepta Therapeutics, Inc. (MM) |
06/10/2010 | 5:14PM | Edgar (US Regulatory) | Current report filing (8-K) | NASDAQ:AVII | Sarepta Therapeutics, Inc. (MM) |
06/10/2010 | 2:15PM | Edgar (US Regulatory) | Confidential Treatment Order (CT ORDER) | NASDAQ:AVII | Sarepta Therapeutics, Inc. (MM) |
06/10/2010 | 2:00PM | Marketwired | AVI BioPharma to Present at ThinkEquity's Mid Year Check-Up on Healthcare Conference | NASDAQ:AVII | Sarepta Therapeutics, Inc. (MM) |
06/10/2010 | 1:30PM | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:AVII | Sarepta Therapeutics, Inc. (MM) |
06/09/2010 | 2:15PM | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:AVII | Sarepta Therapeutics, Inc. (MM) |
06/09/2010 | 2:12PM | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:AVII | Sarepta Therapeutics, Inc. (MM) |
06/09/2010 | 2:10PM | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:AVII | Sarepta Therapeutics, Inc. (MM) |
06/09/2010 | 2:09PM | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:AVII | Sarepta Therapeutics, Inc. (MM) |
06/09/2010 | 2:07PM | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:AVII | Sarepta Therapeutics, Inc. (MM) |
06/09/2010 | 2:06PM | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:AVII | Sarepta Therapeutics, Inc. (MM) |
06/08/2010 | 7:32PM | Edgar (US Regulatory) | Initial Statement of Beneficial Ownership (3) | NASDAQ:AVII | Sarepta Therapeutics, Inc. (MM) |
06/08/2010 | 7:28PM | Edgar (US Regulatory) | Initial Statement of Beneficial Ownership (3) | NASDAQ:AVII | Sarepta Therapeutics, Inc. (MM) |
06/07/2010 | 9:45AM | Marketwired | AVI BioPharma Discloses New Contract With U.S. Government for up to $18 Million to Advance Development of AVI-7100 as H1N1 Flu T | NASDAQ:AVII | Sarepta Therapeutics, Inc. (MM) |
06/07/2010 | 9:21AM | Edgar (US Regulatory) | Current report filing (8-K) | NASDAQ:AVII | Sarepta Therapeutics, Inc. (MM) |
06/03/2010 | 9:46AM | Marketwired | AVI BioPharma to Present at the Jefferies 2010 Global Life Sciences Conference | NASDAQ:AVII | Sarepta Therapeutics, Inc. (MM) |
06/02/2010 | 7:00AM | Marketwired | AVI-4658 Demonstrates First Ever Reported Generation of Greater Than 50% Dystrophin-Positive Muscle Fibers in a Patient Followin | NASDAQ:AVII | Sarepta Therapeutics, Inc. (MM) |
05/24/2010 | 5:01PM | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:AVII | Sarepta Therapeutics, Inc. (MM) |
05/24/2010 | 1:43PM | Edgar (US Regulatory) | Additional Proxy Soliciting Materials (definitive) (DEFA14A) | NASDAQ:AVII | Sarepta Therapeutics, Inc. (MM) |
05/24/2010 | 1:39PM | Edgar (US Regulatory) | Amended Current report filing (8-K/A) | NASDAQ:AVII | Sarepta Therapeutics, Inc. (MM) |
05/18/2010 | 2:53PM | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:AVII | Sarepta Therapeutics, Inc. (MM) |